Mirvetuximab soravtansine for treating folate receptor alpha-positive platinum-resistant advanced epithelial ovarian, fallopian tube or primary peritoneal cancer [ID6442] Draft guidance Technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback